The impact of inflammatory factors on patients with concurrent lung cancer and acute pulmonary embolism
Our findings highlight neutrophilia as a potential biomarker for APE susceptibility in lung cancer patients. Furthermore, elevated uric acid levels and a diminished PLR may serve as valuable indicators of disease severity in this high-risk population. The study underscores the critical need to integrate these inflammatory markers into standardized clinical risk assessment frameworks to optimize therapeutic strategies and improve patient management.
Authors
- Qiong Yi (ORCID: https://orcid.org/0009-0009-1124-7440)
- Yuan Li (ORCID: https://orcid.org/0000-0002-7233-2720)
- Shangjie Wu (ORCID: https://orcid.org/0000-0003-0702-776X)
- Fang Li (ORCID: https://orcid.org/0000-0002-7617-6534)
- Meizhi Li (ORCID: https://orcid.org/0000-0003-4865-3097)
Institutions
- Central South University (CN)
- Second Xiangya Hospital of Central South University (CN)
Publication Details
- Journal
- Frontiers in Cardiovascular Medicine
- Published
- 2025-10-15
- DOI
- https://doi.org/10.3389/fcvm.2025.1636717
- Primary Topic
- Venous Thromboembolism Diagnosis and Management
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Central South University
- Xiangya Hospital, Central South University